HepaFat-Scan

JSON twin: https://www.healthaidb.com/software/hepafat-scan.json

Company Name

Resonance Health

Product URL

https://www.resonancehealth.com/liver-cardiac-solutions/

Company URL

https://www.resonancehealth.com/

Categories

• diagnostic Support
• clinical Care
• imaging Software
• clinical Decision Support
• Diagnostic
• Clinical
• Non-invasive Imaging
• Liver Health Assessment

Summary

HepaFat-Scan is a non-invasive MRI-based solution developed by Resonance Health to accurately assess liver fat content, aiding in the diagnosis and management of hepatic steatosis.

Description

HepaFat-Scan utilizes magnetic resonance imaging (MRI) to evaluate hepatic steatosis by measuring the volumetric liver fat fraction (VLFF), proton density fat fraction (PDFF), and steatosis grade. This non-invasive method provides accurate, reliable, and reproducible results without the need for contrast agents, making it a valuable tool in the management of liver conditions. The process involves a brief MRI scan, secure transmission of DICOM files to Resonance Health's Core Lab, analysis by a team of physicists, and results returned to the physician within two business days. HepaFat-Scan is FDA-cleared and CE-marked, ensuring its regulatory compliance for clinical use. It is intended solely for use by healthcare professionals and is not available for direct purchase by the general public. The technology was developed in collaboration with the University of Western Australia and has been recognized with the Western Australian Innovation of the Year award in 2014. ([prnewswire.com](https://www.prnewswire.com/news-releases/new-non-invasive-technology-diagnoses-fatty-liver-disease-282107571.html?utm_source=openai))

Api Available

unknown

Certifications

• FDA 510(k) (see K201039 / related filings)

Company Founding

2005

Company Offices

• Australia
• United States
• European Union

Compliance

• FDA (510(k) clearance reference K201039 / K231459 for related HepaFat products)

Customers

Data Residency

Resonance Health core lab (Australia - Burswood, Western Australia)

Data Standards

• DICOM

Deployment Model

• cloud

Features

• MRI-based quantitative liver fat fraction (VLFF/PDFF) analysis
• DICOM intake and secure transfer via FAST portal
• Centralised core-lab image quality checks and analysis by physicists
• Standardised HepaFat-Scan reporting (PDF report)
• Rapid turnaround (typically within 2 business days)
• Support for 1.5T and 3T MRI acquisitions
• Vendor-independent analysis (works with multi-vendor MRI DICOMs)
• Validated algorithm with published clinical evidence

Id

SW0753

Integration Partners

Integrations

• FAST secure DICOM transfer portal
• PACS/DICOM-compatible MRI scanners (vendor independent)
• MRI vendors (1.5T and 3T systems)

Languages Supported

• English

Last Updated

2025-10-11

License

commercial

Market Segment

• enterprise
• smb

Optional Modules

Os Platforms

• web

Pricing Details

contact vendor

Pricing Model

subscription

Privacy Features

• Secure transfer and reporting workflow

Product Code

SW0753

Product Name

HepaFat-Scan

Ratings

Regions Available

• United States
• European Union
• Australia

Related Urls

• https://healthairegister.com/radiology/products/resonance-health-hepafat-scan

Release Year

Security Features

• Secure DICOM transmission via FAST portal
• Centralised analysis with controlled access

Specialties

• Hepatology
• Gastroenterology
• Radiology

Support Channels

System Requirements

DICOM-export-capable MRI scanner; internet access and web browser for FAST portal uploads

Target Users

• clinicians
• radiologists
• healthcare professionals

Training Options

Type

product

User Reviews

Version

1.0

Alternatives

See related products

Canonical JSON

{
  "product_name": "HepaFat-Scan",
  "company_name": "Resonance Health",
  "product_url": "https://www.resonancehealth.com/liver-cardiac-solutions/",
  "company_url": "https://www.resonancehealth.com/",
  "related_urls": [
    "https://healthairegister.com/radiology/products/resonance-health-hepafat-scan"
  ],
  "product_code": "SW0753",
  "summary": "HepaFat-Scan is a non-invasive MRI-based solution developed by Resonance Health to accurately assess liver fat content, aiding in the diagnosis and management of hepatic steatosis.",
  "description": "HepaFat-Scan utilizes magnetic resonance imaging (MRI) to evaluate hepatic steatosis by measuring the volumetric liver fat fraction (VLFF), proton density fat fraction (PDFF), and steatosis grade. This non-invasive method provides accurate, reliable, and reproducible results without the need for contrast agents, making it a valuable tool in the management of liver conditions. The process involves a brief MRI scan, secure transmission of DICOM files to Resonance Health's Core Lab, analysis by a team of physicists, and results returned to the physician within two business days. HepaFat-Scan is FDA-cleared and CE-marked, ensuring its regulatory compliance for clinical use. It is intended solely for use by healthcare professionals and is not available for direct purchase by the general public. The technology was developed in collaboration with the University of Western Australia and has been recognized with the Western Australian Innovation of the Year award in 2014. ([prnewswire.com](https://www.prnewswire.com/news-releases/new-non-invasive-technology-diagnoses-fatty-liver-disease-282107571.html?utm_source=openai))",
  "categories": [
    "diagnostic Support",
    "clinical Care",
    "imaging Software",
    "clinical Decision Support",
    "Diagnostic",
    "Clinical",
    "Non-invasive Imaging",
    "Liver Health Assessment"
  ],
  "market_segment": [
    "enterprise",
    "smb"
  ],
  "target_users": [
    "clinicians",
    "radiologists",
    "healthcare professionals"
  ],
  "specialties": [
    "Hepatology",
    "Gastroenterology",
    "Radiology"
  ],
  "regions_available": [
    "United States",
    "European Union",
    "Australia"
  ],
  "languages_supported": [
    "English"
  ],
  "pricing_model": "subscription",
  "pricing_details": "contact vendor",
  "license": "commercial",
  "company_offices": [
    "Australia",
    "United States",
    "European Union"
  ],
  "company_founding": "2005",
  "deployment_model": [
    "cloud"
  ],
  "os_platforms": [
    "web"
  ],
  "features": [
    "MRI-based quantitative liver fat fraction (VLFF/PDFF) analysis",
    "DICOM intake and secure transfer via FAST portal",
    "Centralised core-lab image quality checks and analysis by physicists",
    "Standardised HepaFat-Scan reporting (PDF report)",
    "Rapid turnaround (typically within 2 business days)",
    "Support for 1.5T and 3T MRI acquisitions",
    "Vendor-independent analysis (works with multi-vendor MRI DICOMs)",
    "Validated algorithm with published clinical evidence"
  ],
  "optional_modules": [],
  "integrations": [
    "FAST secure DICOM transfer portal",
    "PACS/DICOM-compatible MRI scanners (vendor independent)",
    "MRI vendors (1.5T and 3T systems)"
  ],
  "data_standards": [
    "DICOM"
  ],
  "api_available": "unknown",
  "system_requirements": "DICOM-export-capable MRI scanner; internet access and web browser for FAST portal uploads",
  "compliance": [
    "FDA (510(k) clearance reference K201039 / K231459 for related HepaFat products)"
  ],
  "certifications": [
    "FDA 510(k) (see K201039 / related filings)"
  ],
  "security_features": [
    "Secure DICOM transmission via FAST portal",
    "Centralised analysis with controlled access"
  ],
  "privacy_features": [
    "Secure transfer and reporting workflow"
  ],
  "data_residency": "Resonance Health core lab (Australia - Burswood, Western Australia)",
  "customers": [],
  "user_reviews": [],
  "ratings": [],
  "support_channels": [],
  "training_options": [],
  "release_year": "",
  "integration_partners": [],
  "id": "SW0753",
  "slug": "hepafat-scan",
  "type": "product",
  "version": "1.0",
  "last_updated": "2025-10-11",
  "links_json": {
    "self": "https://www.healthaidb.com/software/hepafat-scan.json"
  }
}